These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic pharmacomodulation of nucleoside analogues and gene therapy for AIDS and cancer. Guettari N; Loubière L; Caruso M; Klatzmann D Antibiot Chemother (1971); 1996; 48():198-204. PubMed ID: 8726526 [No Abstract] [Full Text] [Related]
3. Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells. Vile RG; Diaz RM; Castleden S; Chong H Biochem Soc Trans; 1997 May; 25(2):717-22. PubMed ID: 9191190 [No Abstract] [Full Text] [Related]
4. Gene therapy: different strategies for different applications. American Society of Gene Therapy: First Annual Meeting, Seattle, Washington, USA, 28-31 May 1998. Caplen NJ Mol Med Today; 1998 Sep; 4(9):374-5. PubMed ID: 9882148 [No Abstract] [Full Text] [Related]
5. Adenovirus-mediated herpes simplex thymidine kinase gene therapy for brain tumors. Sandmair AM; Vapalahti M; Ylä-Herttuala S Adv Exp Med Biol; 2000; 465():163-70. PubMed ID: 10810624 [No Abstract] [Full Text] [Related]
17. Cancer gene therapy: present status and future directions. Nabel GJ Ernst Schering Res Found Workshop; 2003; (43):81-8. PubMed ID: 12894452 [No Abstract] [Full Text] [Related]